ReP USP - Resultado da busca

Artigo de periodico-carta/editorial
Empowering voices: inspiring women in medicinal chemistry [Editorial] (2024)
Blanco, Maria Jesus ; Bronson, Joanne J ; DiMauro, Erin F ; Dzierba, Carolyn ; Eggen, MariJean ; Garner, Amanda L ; Georg, Gunda ; Giarolla, Jeanine ; Goodwin, Nicole C ; Davies, Melissa C. Grenier ; Luevano, Carrie Haskell ; Holzgrabe, Ulrike ; Huang, Rong ; Lagiakos, H. Rachel ; Leftheris, Katerina ; Martin, Yvonne; Matos, Maria João ; Dracka, Tricia L. May
Source: Journal of Medicinal Chemistry. Unidade: FCF
Subjects: MULHERES, QUÍMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BLANCO, Maria Jesus et al. Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Disponível em: https://dx.doi.org/10.1021/acsmedchemlett.4c00097. Acesso em: 09 nov. 2024. , 2024
APA
Blanco, M. J., Bronson, J. J., DiMauro, E. F., Dzierba, C., Eggen, M. J., Garner, A. L., et al. (2024). Empowering voices: inspiring women in medicinal chemistry [Editorial]. Journal of Medicinal Chemistry. Washington: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. doi:10.1021/acsmedchemlett.4c00097
NLM
Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097
Vancouver
Blanco MJ, Bronson JJ, DiMauro EF, Dzierba C, Eggen MJ, Garner AL, Georg G, Giarolla J, Goodwin NC, Davies MCG, Luevano CH, Holzgrabe U, Huang R, Lagiakos HR, Leftheris K, Martin Y, Matos MJ, Dracka TLM. Empowering voices: inspiring women in medicinal chemistry [Editorial] [Internet]. Journal of Medicinal Chemistry. 2024 ; 67 4251-4258.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1021/acsmedchemlett.4c00097
Artigo de periodico
Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes (2024)
Herrerias, Bruna Viggiano; Fernandes, Renan Caprucho; Gonzaga, Rodrigo Vieira ; Balista, Priscila Alves; Dario, Michelli Ferrera ; Sobreira, Flavia
Source: Archives of Health. Unidade: FCF
Subjects: RESISTÊNCIA MICROBIANA ÀS DROGAS, AGENTES ANTIMICROBIANOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HERRERIAS, Bruna Viggiano et al. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes. Archives of Health, v. 5, n. 1, p. 17-26, 2024Tradução . . Disponível em: https://dx.doi.org/10.46919/archv5n1-003. Acesso em: 09 nov. 2024.
APA
Herrerias, B. V., Fernandes, R. C., Gonzaga, R. V., Balista, P. A., Dario, M. F., & Sobreira, F. (2024). Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes. Archives of Health, 5( 1), 17-26. doi:10.46919/archv5n1-003
NLM
Herrerias BV, Fernandes RC, Gonzaga RV, Balista PA, Dario MF, Sobreira F. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes [Internet]. Archives of Health. 2024 ; 5( 1): 17-26.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.46919/archv5n1-003
Vancouver
Herrerias BV, Fernandes RC, Gonzaga RV, Balista PA, Dario MF, Sobreira F. Efeito sinérgico antibacteriano da associação entre óleos voláteis e antimicrobianos frente a bactérias resistentes [Internet]. Archives of Health. 2024 ; 5( 1): 17-26.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.46919/archv5n1-003
Artigo de periodico
Potential use of bixin beyond function as a natural colourant in food and cosmetics (2024)
Takamoto, Rafael Teruiti de Oliveira; Hübner, Alexandra Almeida; Matuo, Míriam Cristina Sakuragui; Kikuchi, Irene Satiko
Source: Natural Product Research. Unidade: FCF
Subjects: CAROTENOIDES, URUCUM
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TAKAMOTO, Rafael Teruiti de Oliveira et al. Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research, 2024Tradução . . Disponível em: https://dx.doi.org/10.1080/14786419.2024.2350634. Acesso em: 09 nov. 2024.
APA
Takamoto, R. T. de O., Hübner, A. A., Matuo, M. C. S., & Kikuchi, I. S. (2024). Potential use of bixin beyond function as a natural colourant in food and cosmetics. Natural Product Research. doi:10.1080/14786419.2024.2350634
NLM
Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634
Vancouver
Takamoto RT de O, Hübner AA, Matuo MCS, Kikuchi IS. Potential use of bixin beyond function as a natural colourant in food and cosmetics [Internet]. Natural Product Research. 2024 ;[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1080/14786419.2024.2350634
Artigo de periodico
Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews (2024)
Visacri, Marilia Berlofa ; Ribeiro, Mayra Carvalho; Komoda, Denis Satoshi; Duarte, Bruno Kosa Lino; Corrêa, Carlos Roberto Silveira; Maia, Flávia de Oliveira Motta ; Alves, Daniela Fernanda dos Santos
Source: Value in Health Regional Issues. Unidade: FCF
Subjects: MIELOMA MÚLTIPLO, REVISÃO SISTEMÁTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VISACRI, Marilia Berlofa et al. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, v. 43, p. 1-10 art. 100998, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.vhri.2024.100998. Acesso em: 09 nov. 2024.
APA
Visacri, M. B., Ribeiro, M. C., Komoda, D. S., Duarte, B. K. L., Corrêa, C. R. S., Maia, F. de O. M., & Alves, D. F. dos S. (2024). Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews. Value in Health Regional Issues, 43, 1-10 art. 100998. doi:10.1016/j.vhri.2024.100998
NLM
Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998
Vancouver
Visacri MB, Ribeiro MC, Komoda DS, Duarte BKL, Corrêa CRS, Maia F de OM, Alves DF dos S. Lenalidomide or thalidomide for transplant-ineligible patients with newly diagnosed multiple myeloma? an overview of systematic reviews [Internet]. Value in Health Regional Issues. 2024 ; 43 1-10 art. 100998.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.vhri.2024.100998
Artigo de periodico
Dendrimers as drug delivery systems for oncotherapy: current status of promising applications (2024)
Sueyoshi, Sophia Mikiko Oliveira; Silva, João Vitor da ; Guizze, Felipe; Giarolla, Jeanine
Source: International Journal of Pharmaceutics. Unidade: FCF
Subjects: MEDICAMENTO, NEOPLASIAS, FARMACOCINÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SUEYOSHI, Sophia Mikiko Oliveira et al. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications. International Journal of Pharmaceutics, v. 663, p. 1-33 art. 124573, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.ijpharm.2024.124573. Acesso em: 09 nov. 2024.
APA
Sueyoshi, S. M. O., Silva, J. V. da, Guizze, F., & Giarolla, J. (2024). Dendrimers as drug delivery systems for oncotherapy: current status of promising applications. International Journal of Pharmaceutics, 663, 1-33 art. 124573. doi:10.1016/j.ijpharm.2024.124573
NLM
Sueyoshi SMO, Silva JV da, Guizze F, Giarolla J. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications [Internet]. International Journal of Pharmaceutics. 2024 ; 663 1-33 art. 124573.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.ijpharm.2024.124573
Vancouver
Sueyoshi SMO, Silva JV da, Guizze F, Giarolla J. Dendrimers as drug delivery systems for oncotherapy: current status of promising applications [Internet]. International Journal of Pharmaceutics. 2024 ; 663 1-33 art. 124573.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.ijpharm.2024.124573
Artigo de periodico
A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma (2024)
Park, Ji Won; Pereira, Taynna Tatiane; Rotta, Inajara ; Lima, Tácio de Mendonça ; Aguiar, Patrícia Melo ; Visacri, Marilia Berlofa
Source: International Journal of Clinical Pharmacy. Unidade: FCF
Subjects: SERVIÇOS FARMACÊUTICOS, MIELOMA MÚLTIPLO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARK, Ji Won et al. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma. International Journal of Clinical Pharmacy, 2024Tradução . . Disponível em: https://dx.doi.org/10.1007/s11096-024-01787-x. Acesso em: 09 nov. 2024.
APA
Park, J. W., Pereira, T. T., Rotta, I., Lima, T. de M., Aguiar, P. M., & Visacri, M. B. (2024). A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma. International Journal of Clinical Pharmacy. doi:10.1007/s11096-024-01787-x
NLM
Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma [Internet]. International Journal of Clinical Pharmacy. 2024 ;[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1007/s11096-024-01787-x
Vancouver
Park JW, Pereira TT, Rotta I, Lima T de M, Aguiar PM, Visacri MB. A scoping review of pharmacists' clinical activities and impact on the care of patients with multiple myeloma [Internet]. International Journal of Clinical Pharmacy. 2024 ;[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1007/s11096-024-01787-x
Artigo de periodico
Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks (2024)
Kumbhar, Popat; Kolekar, Kaustubh; Vishwas, Sukriti; Shetti, Priya; Kumbar, Vijay; Pinto, Terezinha de Jesus Andreoli ; Santos, Ana Cláudia Paiva ; Veiga, Francisco; Gupta, Guarav; Singh, Sachin Kumar; Dua, Kamal; Disouza, John; Patravale, Vandana
Source: Ageing Research Reviews. Unidade: FCF
Subjects: DEGENERAÇÃO MACULAR, NANOPARTÍCULAS, CÉLULAS-TRONCO, ENSAIO CLÍNICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
KUMBHAR, Popat et al. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Research Reviews, v. 98, p. 1-20 art. 102322, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102322. Acesso em: 09 nov. 2024.
APA
Kumbhar, P., Kolekar, K., Vishwas, S., Shetti, P., Kumbar, V., Pinto, T. de J. A., et al. (2024). Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks. Ageing Research Reviews, 98, 1-20 art. 102322. doi:10.1016/j.arr.2024.102322
NLM
Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Pinto T de JA, Santos ACP, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks [Internet]. Ageing Research Reviews. 2024 ; 98 1-20 art. 102322.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102322
Vancouver
Kumbhar P, Kolekar K, Vishwas S, Shetti P, Kumbar V, Pinto T de JA, Santos ACP, Veiga F, Gupta G, Singh SK, Dua K, Disouza J, Patravale V. Treatment avenues for age-related macular degeneration: Breakthroughs and bottlenecks [Internet]. Ageing Research Reviews. 2024 ; 98 1-20 art. 102322.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102322
Artigo de periodico
Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways (2024)
Borges, Lara Gimenez; Alves, Thais Nascimento de Oliveira; Vassiliades, Sandra Valeria ; Parise Filho, Roberto
Source: Current Medicinal Chemistry. Unidades: FCF, IQ
Subjects: FÁRMACOS, ANALGÉSICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BORGES, Lara Gimenez et al. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways. Current Medicinal Chemistry, 2024Tradução . . Disponível em: https://dx.doi.org/10.2174/0109298673310050240821054652. Acesso em: 09 nov. 2024.
APA
Borges, L. G., Alves, T. N. de O., Vassiliades, S. V., & Parise Filho, R. (2024). Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways. Current Medicinal Chemistry. doi:10.2174/0109298673310050240821054652
NLM
Borges LG, Alves TN de O, Vassiliades SV, Parise Filho R. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways [Internet]. Current Medicinal Chemistry. 2024 ;[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.2174/0109298673310050240821054652
Vancouver
Borges LG, Alves TN de O, Vassiliades SV, Parise Filho R. Natural and synthetic capsaicin analogues: a comprehensive review of biological effects and synthetic pathways [Internet]. Current Medicinal Chemistry. 2024 ;[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.2174/0109298673310050240821054652
Trabalho de evento-resumo
Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus (2024)
Contelli, Ana P; Ferraz, Gustavo C; Ferraz, Wítor R; Penteado, André Berndt ; Trossini, Gustavo Henrique Goulart ; Pedrozo, Eliane Correa
Source: Anais. Conference titles: Reunião Anual da Sociedade Brasileira de Química - RASBQ. Unidades: FCF, EEL
Subjects: ESCORPIÕES, VENENOS DE ORIGEM ANIMAL, DOENÇAS NEGLIGENCIADAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CONTELLI, Ana P et al. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. 2024, Anais.. São Paulo: Sociedade Brasileira de Química - SBQ, 2024. Disponível em: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/730_1708183047.pdf. Acesso em: 09 nov. 2024.
APA
Contelli, A. P., Ferraz, G. C., Ferraz, W. R., Penteado, A. B., Trossini, G. H. G., & Pedrozo, E. C. (2024). Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus. In Anais. São Paulo: Sociedade Brasileira de Química - SBQ. Recuperado de https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/730_1708183047.pdf
NLM
Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 nov. 09 ] Available from: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/730_1708183047.pdf
Vancouver
Contelli AP, Ferraz GC, Ferraz WR, Penteado AB, Trossini GHG, Pedrozo EC. Computational modeling of Angiotensin Converting Enzyme I inhibition by Ts3 and Ts10 toxins, present in the venom of the scorpion Tityus serrulatus [Internet]. Anais. 2024 ;[citado 2024 nov. 09 ] Available from: https://www.eventweb.com.br/rasbq2024/specific-files/manuscripts/rasbq2024/730_1708183047.pdf
Artigo de periodico
Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment (2024)
Passarin, Paula Beatriz Silva ; Lourenço, Felipe Rebello
Source: Journal of Pharmaceutical and Biomedical Analysis. Unidade: FCF
Subjects: INDÚSTRIA FARMACÊUTICA, CROMATOGRAFIA LÍQUIDA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSARIN, Paula Beatriz Silva e LOURENÇO, Felipe Rebello. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, v. 239, p. 1-12, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.jpba.2023.115907. Acesso em: 09 nov. 2024.
APA
Passarin, P. B. S., & Lourenço, F. R. (2024). Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment. Journal of Pharmaceutical and Biomedical Analysis, 239, 1-12. doi:10.1016/j.jpba.2023.115907
NLM
Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
Vancouver
Passarin PBS, Lourenço FR. Enhancing analytical development in the pharmaceutical industry: a DoE-QSRR model for virtual method operable design region assessment [Internet]. Journal of Pharmaceutical and Biomedical Analysis. 2024 ; 239 1-12.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.jpba.2023.115907
Artigo de periodico
Enzymes for dermatological use (2024)
Nascimento, Natália Santos do ; Obreque, Karin Mariana Torres ; Oliveira, Camila Areias de; Cunha, Jheniffer Rabelo ; Baby, André Rolim ; Long, Paul Frederick ; Young, Antony R ; Rangel-Yagui, Carlota de Oliveira
Source: Experimental Dermatology. Unidade: FCF
Subjects: ENZIMAS, DERMATOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
NASCIMENTO, Natália Santos do et al. Enzymes for dermatological use. Experimental Dermatology, v. 33, p. 1-20, 2024Tradução . . Disponível em: https://dx.doi.org/10.1111/exd.15008. Acesso em: 09 nov. 2024.
APA
Nascimento, N. S. do, Obreque, K. M. T., Oliveira, C. A. de, Cunha, J. R., Baby, A. R., Long, P. F., et al. (2024). Enzymes for dermatological use. Experimental Dermatology, 33, 1-20. doi:10.1111/exd.15008
NLM
Nascimento NS do, Obreque KMT, Oliveira CA de, Cunha JR, Baby AR, Long PF, Young AR, Rangel-Yagui C de O. Enzymes for dermatological use [Internet]. Experimental Dermatology. 2024 ; 33 1-20.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1111/exd.15008
Vancouver
Nascimento NS do, Obreque KMT, Oliveira CA de, Cunha JR, Baby AR, Long PF, Young AR, Rangel-Yagui C de O. Enzymes for dermatological use [Internet]. Experimental Dermatology. 2024 ; 33 1-20.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1111/exd.15008
Artigo de periodico
The scenario of clays and clay minerals use in cosmetics/Dermocosmetics (2024)
Sarruf, Fernanda Daud ; Contreras, Vecxi Judith Pereda; Martinez, Renata Miliani ; Velasco, Maria Valéria Robles ; Baby, André Rolim
Source: Cosmetics. Unidade: FCF
Subjects: ARGILAS, COSMÉTICOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SARRUF, Fernanda Daud et al. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, v. 11, p. 1-21, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/cosmetics11010007. Acesso em: 09 nov. 2024.
APA
Sarruf, F. D., Contreras, V. J. P., Martinez, R. M., Velasco, M. V. R., & Baby, A. R. (2024). The scenario of clays and clay minerals use in cosmetics/Dermocosmetics. Cosmetics, 11, 1-21. doi:10.3390/cosmetics11010007
NLM
Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007
Vancouver
Sarruf FD, Contreras VJP, Martinez RM, Velasco MVR, Baby AR. The scenario of clays and clay minerals use in cosmetics/Dermocosmetics [Internet]. Cosmetics. 2024 ; 11 1-21.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3390/cosmetics11010007
Artigo de periodico
Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system (2024)
Vieira, Aline Rocha; Oliveira, Aline Furtado; Pessoa, Fabiana Vieira Lima Solino ; Miranda, Beatriz Nogueira Messias de; Baby, André Rolim
Source: Scientia Pharmaceutica. Unidade: FCF
Subjects: NANOPARTÍCULAS, GEOMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA, Aline Rocha et al. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system. Scientia Pharmaceutica, v. 92, n. 3, p. 1-17 art. 43, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/scipharm92030043. Acesso em: 09 nov. 2024.
APA
Vieira, A. R., Oliveira, A. F., Pessoa, F. V. L. S., Miranda, B. N. M. de, & Baby, A. R. (2024). Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system. Scientia Pharmaceutica, 92( 3), 1-17 art. 43. doi:10.3390/scipharm92030043
NLM
Vieira AR, Oliveira AF, Pessoa FVLS, Miranda BNM de, Baby AR. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system [Internet]. Scientia Pharmaceutica. 2024 ; 92( 3): 1-17 art. 43.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3390/scipharm92030043
Vancouver
Vieira AR, Oliveira AF, Pessoa FVLS, Miranda BNM de, Baby AR. Advances in the production of PBCA microparticles using a micromixer with HH-Geometry in a microfluidic system [Internet]. Scientia Pharmaceutica. 2024 ; 92( 3): 1-17 art. 43.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3390/scipharm92030043
Artigo de jornal
Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento (2024)
Parise Filho, Roberto
Source: Estadão. Unidade: FCF
Subjects: MEDICAMENTO, COVID-19
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARISE FILHO, Roberto. Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento. Tradução . Estadão, São Paulo, 2024. , v. 21 fe 2024Disponível em: https://www.estadao.com.br/saude/azitromicina-o-que-e-para-que-serve-e-quais-os-cuidados-ao-usar-esse-medicamento/?srsltid=AfmBOooeBFwVlAVeeXi5kcar670EvofmmrMmV3EzzivkZ3bxb1zi8i-a. Acesso em: 09 nov. 2024.
APA
Parise Filho, R. (2024). Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento. Estadão. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. Recuperado de https://www.estadao.com.br/saude/azitromicina-o-que-e-para-que-serve-e-quais-os-cuidados-ao-usar-esse-medicamento/?srsltid=AfmBOooeBFwVlAVeeXi5kcar670EvofmmrMmV3EzzivkZ3bxb1zi8i-a
NLM
Parise Filho R. Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento [Internet]. Estadão. 2024 ;21 fe 2024[citado 2024 nov. 09 ] Available from: https://www.estadao.com.br/saude/azitromicina-o-que-e-para-que-serve-e-quais-os-cuidados-ao-usar-esse-medicamento/?srsltid=AfmBOooeBFwVlAVeeXi5kcar670EvofmmrMmV3EzzivkZ3bxb1zi8i-a
Vancouver
Parise Filho R. Azitromicina: o que é, para que serve e quais os cuidados ao usar esse medicamento [Internet]. Estadão. 2024 ;21 fe 2024[citado 2024 nov. 09 ] Available from: https://www.estadao.com.br/saude/azitromicina-o-que-e-para-que-serve-e-quais-os-cuidados-ao-usar-esse-medicamento/?srsltid=AfmBOooeBFwVlAVeeXi5kcar670EvofmmrMmV3EzzivkZ3bxb1zi8i-a
Artigo de periodico
Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs (2024)
Almeida, Lígia Scandoglieri de; Chiavassa, Luísa Donatto ; Brito, Charles de Lima; Gatti, Fernando de Moura ; Trossini, Gustavo Henrique Goulart ; La Scalea, Mauro Aquiles
Source: Journal of Applied Electrochemistry. Unidade: FCF
Subjects: ELETROQUÍMICA, VOLTAMETRIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ALMEIDA, Lígia Scandoglieri de et al. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs. Journal of Applied Electrochemistry, v. 54, p. 41-52, 2024Tradução . . Disponível em: https://doi.org/10.1007/s10800-023-01945-5. Acesso em: 09 nov. 2024.
APA
Almeida, L. S. de, Chiavassa, L. D., Brito, C. de L., Gatti, F. de M., Trossini, G. H. G., & La Scalea, M. A. (2024). Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs. Journal of Applied Electrochemistry, 54, 41-52. doi:10.1007/s10800-023-01945-5
NLM
Almeida LS de, Chiavassa LD, Brito C de L, Gatti F de M, Trossini GHG, La Scalea MA. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs [Internet]. Journal of Applied Electrochemistry. 2024 ; 54 41-52.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s10800-023-01945-5
Vancouver
Almeida LS de, Chiavassa LD, Brito C de L, Gatti F de M, Trossini GHG, La Scalea MA. Voltammetric study in aqueous media of two new sulfonylhydrazone derivatives as candidates for antichagasic drugs [Internet]. Journal of Applied Electrochemistry. 2024 ; 54 41-52.[citado 2024 nov. 09 ] Available from: https://doi.org/10.1007/s10800-023-01945-5
Artigo de periodico
Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation (2024)
Bashir, Bushra; Alam, Shahbaz; Khandale, Nikhil; Birla, Devendra; Vishwas, Sukriti ; Pandey, Narendra Kumar; Gupta, Gaurav; Paudel, Keshav Raj ; Dureja, Harish; Kumar, Puneet; Singh, Thakur Gurjeet; Kuppusamy, Gowthamarajan; Zacconi, Flavia C; Pinto, Terezinha de Jesus Andreoli ; Dhanasekaran, Muralikrishnan; Gulati, Monica; Dua, Kamal ; Singh, Sachin Kumar
Source: Ageing Research Reviews. Unidade: FCF
Subjects: DOENÇAS NEURODEGENERATIVAS, ENVELHECIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BASHIR, Bushra et al. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, v. 95, p. 1-16 art. 102236, 2024Tradução . . Disponível em: https://dx.doi.org/10.1016/j.arr.2024.102236. Acesso em: 09 nov. 2024.
APA
Bashir, B., Alam, S., Khandale, N., Birla, D., Vishwas, S., Pandey, N. K., et al. (2024). Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation. Ageing Research Reviews, 95, 1-16 art. 102236. doi:10.1016/j.arr.2024.102236
NLM
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Vancouver
Bashir B, Alam S, Khandale N, Birla D, Vishwas S, Pandey NK, Gupta G, Paudel KR, Dureja H, Kumar P, Singh TG, Kuppusamy G, Zacconi FC, Pinto T de JA, Dhanasekaran M, Gulati M, Dua K, Singh SK. Opening avenues for treatment of neurodegenerative disease using post-biotics: breakthroughs and bottlenecks in clinical translation [Internet]. Ageing Research Reviews. 2024 ; 95 1-16 art. 102236.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1016/j.arr.2024.102236
Artigo de periodico
In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors (2024)
Yousef, Malaz ; O’Croinin, Conor; Le, Tyson S; Park, Chulhun ; Zuo, Jieyu; Bou-Chacra, Nadia Araci ; Davies, Neal M ; Löbenberg, Raimar
Source: Pharmaceutics. Unidade: FCF
Subjects: FARMACOCINÉTICA, FARMACODINÂMICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
YOUSEF, Malaz et al. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, v. 16, n. 6 p. 1-13 art. 768, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16060768. Acesso em: 09 nov. 2024.
APA
Yousef, M., O’Croinin, C., Le, T. S., Park, C., Zuo, J., Bou-Chacra, N. A., et al. (2024). In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors. Pharmaceutics, 16( 6 p. 1-13 art. 768). doi:10.3390/pharmaceutics16060768
NLM
Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
Vancouver
Yousef M, O’Croinin C, Le TS, Park C, Zuo J, Bou-Chacra NA, Davies NM, Löbenberg R. In vitro predictive model for intestinal lymphatic uptake: exploration of additional enhancers and inhibitors [Internet]. Pharmaceutics. 2024 ; 16( 6 p. 1-13 art. 768):[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16060768
Artigo de periodico
1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction (2024)
Hornink, Milene Macedo ; Toledo, Mônica Franco Zannini Junqueira ; Pimenta, Daniel Carvalho ; Paschoalin, Caio; Silva, Pamela M; Figlino, Giuseppe E; Aguiar, Eurípedes; Cervi, Gustavo ; Ribeiro, Francisco Wanderson Moreira; Correra, Thiago Carita ; Ferry, Angélique; Stefani, Hélio Alexandre
Source: ACS Omega. Unidades: FCF, IQ
Subjects: COMPOSTOS AROMÁTICOS, AMIDAS, LIPÍDEOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
HORNINK, Milene Macedo et al. 1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction. ACS Omega, v. 9, n. 29, p. 31732–31744, 2024Tradução . . Disponível em: https://dx.doi.org/10.1021/acsomega.4c02645. Acesso em: 09 nov. 2024.
APA
Hornink, M. M., Toledo, M. F. Z. J., Pimenta, D. C., Paschoalin, C., Silva, P. M., Figlino, G. E., et al. (2024). 1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction. ACS Omega, 9( 29), 31732–31744. doi:10.1021/acsomega.4c02645
NLM
Hornink MM, Toledo MFZJ, Pimenta DC, Paschoalin C, Silva PM, Figlino GE, Aguiar E, Cervi G, Ribeiro FWM, Correra TC, Ferry A, Stefani HA. 1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction [Internet]. ACS Omega. 2024 ; 9( 29): 31732–31744.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1021/acsomega.4c02645
Vancouver
Hornink MM, Toledo MFZJ, Pimenta DC, Paschoalin C, Silva PM, Figlino GE, Aguiar E, Cervi G, Ribeiro FWM, Correra TC, Ferry A, Stefani HA. 1-Iodoglycal: a versatile intermediate for the synthesis of D-Glyco amides and esters employing Carbonylative cross-coupling reaction [Internet]. ACS Omega. 2024 ; 9( 29): 31732–31744.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.1021/acsomega.4c02645
Artigo de periodico
Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats (2024)
Souza, Aline de ; Scarim, Cauê Benito ; Cotrim, Paulo César ; Barbosa Junior, Fernando ; Rocha, Bruno Alves ; Calixto, Leandro Augusto ; Correia, Cristiano de Jesus; Araujo, Gabriel Lima Barros de ; Löbenberg, Raimar ; Bou-Chacra, Nadia Araci ; Faloppa, Ana Cristina Breithaupt
Source: Nanomedicine. Unidades: FM, FCFRP, FCF
Subjects: LEISHMANIA, SISTEMA LINFÁTICO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUZA, Aline de et al. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, v. 19, n. 4, p. 293-301, 2024Tradução . . Disponível em: https://dx.doi.org/10.2217/nnm-2023-0263. Acesso em: 09 nov. 2024.
APA
Souza, A. de, Scarim, C. B., Cotrim, P. C., Barbosa Junior, F., Rocha, B. A., Calixto, L. A., et al. (2024). Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats. Nanomedicine, 19( 4), 293-301. doi:10.2217/nnm-2023-0263
NLM
Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
Vancouver
Souza A de, Scarim CB, Cotrim PC, Barbosa Junior F, Rocha BA, Calixto LA, Correia C de J, Araujo GLB de, Löbenberg R, Bou-Chacra NA, Faloppa ACB. Hydroxymethylnitrofurazone lymphatic uptake with nanostructured lipid carrier after oral administration in rats [Internet]. Nanomedicine. 2024 ; 19( 4): 293-301.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.2217/nnm-2023-0263
Artigo de periodico
Drug nanocrystals in oral absorption: factors that influence pharmacokinetics (2024)
Macedo, Luiza de Oliveira ; Masiero, Jéssica Fagionato ; Bou-Chacra, Nadia Araci
Source: Pharmaceutics. Unidade: FCF
Subjects: FARMACOCINÉTICA, BIODISPONIBILIDADE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MACEDO, Luiza de Oliveira e MASIERO, Jéssica Fagionato e BOU-CHACRA, Nadia Araci. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, v. 16, n. 9, p. 1-21 art. 1141, 2024Tradução . . Disponível em: https://dx.doi.org/10.3390/pharmaceutics16091141. Acesso em: 09 nov. 2024.
APA
Macedo, L. de O., Masiero, J. F., & Bou-Chacra, N. A. (2024). Drug nanocrystals in oral absorption: factors that influence pharmacokinetics. Pharmaceutics, 16( 9), 1-21 art. 1141. doi:10.3390/pharmaceutics16091141
NLM
Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141
Vancouver
Macedo L de O, Masiero JF, Bou-Chacra NA. Drug nanocrystals in oral absorption: factors that influence pharmacokinetics [Internet]. Pharmaceutics. 2024 ; 16( 9): 1-21 art. 1141.[citado 2024 nov. 09 ] Available from: https://dx.doi.org/10.3390/pharmaceutics16091141

USP Schools

ReP

Filtros

Document Types

USP Schools

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Publisher

Conference titles

Countries/Territories

Grupo de pesquisa

Funding Agencies

Indexado em

Normalized affiliation

Non normalized affiliation

Countries of institutions of collaboration